GVD regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Overview
Overview
GVD regimen refers to a regimen consisting of gemcitabine, vinorelbine, doxorubicin used to treat Hodgkin’s lymphoma.[1]
Regimen
Regimen
GGemcitabine
VVinorelbine
DDoxorubicin
References
References
- ↑ 1.0 1.1 Bartlett NL, Niedzwiecki D, Johnson JL, Friedberg JW, Johnson KB, van Besien K; et al. (2007). “Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin’s lymphoma: CALGB 59804”. Ann Oncol. 18 (6): 1071–9. doi:10.1093/annonc/mdm090. PMID 17426059.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH